Supervised clustering of peripheral immune cells associated with clinical response to checkpoint inhibitor therapy in patients with advanced melanoma.

Immunooncol Technol · 2023 · PMC10558712 · PMID 37810199

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The most striking difference between the two groups was the highly significant relative and absolute increase in CD4+ EM T-cell subsets, specifically the EM3, EM4, and EM6 subsets, which was only seen in responders.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.